Navigation Links
Cephalon Announces Strong Third Quarter Financial Results
Date:11/8/2007

Company Also Announces Agreement in Principle with U.S. Attorney's Office;

Earnings Exceed Company Guidance; Company Again Increases 2007 Earnings Guidance and Introduces 2008 Guidance

FRAZER, Pa., Nov. 8 /PRNewswire-FirstCall/ -- Cephalon, Inc. (Nasdaq: CEPH) today reported third quarter 2007 sales of $428.7 million, compared to adjusted sales of $457.2 million for the third quarter of 2006 and within the company's previously issued guidance. Basic loss per common share for the third quarter of 2007 was $4.58. Excluding the settlement reserve increase, amortization expense and certain other items, basic adjusted income per common share during the quarter was $1.08, which compares to $1.71 for the third quarter of 2006 and exceeds the high end of the company's guidance range of $0.85 to $0.95.

During the third quarter, central nervous system (CNS) franchise sales increased 9 percent to $230.9 million and the pain franchise reported strong sales of $121.8 million, a decrease of only 33 percent despite generic competition to ACTIQ(R). Sales of other products were $76.0 million, an increase of 20 percent over the same period last year.

The company also announced that it has reached an agreement in principle with the U.S. Attorney's Office in Philadelphia and the U.S. Department of Justice with respect to the previously disclosed investigation of the company's sales and marketing practices. The company expects to pay $425 million as part of a comprehensive settlement of Federal and related state Medicaid claims. The company has increased its existing financial reserves for this matter accordingly. In addition, the company will agree to a single misdemeanor violation of the U.S. Food, Drug, and Cosmetic Act and will enter into a corporate integrity agreement with the Office of Inspector General of the U.S. Department of Health and Human Services. The terms of the settlement are subject to the final negotiation and execution o
'/>"/>

SOURCE Cephalon, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related biology technology :

1. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
2. Cephalon, Inc. Announces Agreement to Acquire AMRIX, A Once-Daily Extended-Release Muscle Relaxant
3. Cephalon Reinforces Important Prescribing and Dosing Information for FENTORA
4. Cephalon Submits New Drug Application for TREANDA for the Treatment of Chronic Lymphocytic Leukemia
5. Cephalon Quarterly Conference Call Invitation
6. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
7. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
8. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
9. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
10. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
11. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...Dec. 2 /PRNewswire-Asia/ -- Simcere Pharmaceutical..., a leading pharmaceutical company,specializing in...branded,generic and proprietary pharmaceuticals in... been included in China,s National Drug Reimbursem...istry of Human Resources and Social,Security on No...
(Date:12/2/2009)... According to the National Institut... diagnosed with diabetes already have some stage o...age to the retina caused by leaky blood vessels, i...es and is one of the most feared diabetic complica...who,ve had diabetes for 10 years or more will expe...
(Date:12/1/2009)... Reportlinker.com announces that a ...alogue: ,, Industrial Enzymes - A Global Marke...431/Industrial-Enzymes---A-Global-Market-Report.ht...y with few strong players and a host of small supp...petition and commoditization characterize the indu...
(Date:12/1/2009)...ader Richard Gephardt Brings Together A-List from ...s for "Best and Brightest Forum on Medical Innova...e-USNewswire/ -- Several of New Jersey,s most prom...icine and technology gathered today at the Liberty...al innovation in New Jersey, and throughout the Un...
Breaking Biology Technology:Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 2Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 3Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 2Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 3Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 4Reportlinker Adds Industrial Enzymes - A Global Market Report 2Reportlinker Adds Industrial Enzymes - A Global Market Report 3Reportlinker Adds Industrial Enzymes - A Global Market Report 4Reportlinker Adds Industrial Enzymes - A Global Market Report 5Reportlinker Adds Industrial Enzymes - A Global Market Report 6Reportlinker Adds Industrial Enzymes - A Global Market Report 7Reportlinker Adds Industrial Enzymes - A Global Market Report 8Reportlinker Adds Industrial Enzymes - A Global Market Report 9Reportlinker Adds Industrial Enzymes - A Global Market Report 10New Jersey's Best and Brightest Minds Discuss Challenges Facing Medical Innovation, Call for Policies to Preserve U.S. Leadership in Research and Development 2New Jersey's Best and Brightest Minds Discuss Challenges Facing Medical Innovation, Call for Policies to Preserve U.S. Leadership in Research and Development 3New Jersey's Best and Brightest Minds Discuss Challenges Facing Medical Innovation, Call for Policies to Preserve U.S. Leadership in Research and Development 4New Jersey's Best and Brightest Minds Discuss Challenges Facing Medical Innovation, Call for Policies to Preserve U.S. Leadership in Research and Development 5
...e, Wis. - Local angel investor network Silicon P...Clearent, LLC , which is developing a next-generat...frame computer. , ,It,s not unusual for Wisconsin-..., and Pehr Anderson, managing director of Silicon ... at the right time and in the right place. , ,"Ou...
... Wis. - Wisconsin has joined 33 other states in f...ip manufacturers. , ,States filed the complaint in...turers of dynamic random access memory microchips ...isconsin antitrust laws from 1998 to 2002. , ,The ... coordinate prices for the DRAM microchips used in...
... Wis. - When her daughter Molly was 18 months old...about her, especially compared to other children t...es and only repeated language she heard, she pulle... and she showed unusual sensitivity to sounds such...ing with a doll, and pretending to bathe and play ...
Other Biology Technology:Wisconsin joins price-fixing suit vs. D-RAM makers 2RelateNow.com goes live to tackle autism 2RelateNow.com goes live to tackle autism 3RelateNow.com goes live to tackle autism 4
(Date:12/3/2009)... Coral reef fish can undergo a personality change ...udy suggesting that climate change may make some s...pecies of young damselfish on Australia,s Great Ba... reef fish are either consistently timid, or consi...s are even more marked as water temperatures rise....
(Date:12/3/2009)... Forest dwellers must be included in the design of...o avoid a humanitarian crisis, according to a scie...ay in Nature , Dr Simon Lewis argues that at leas...t Copenhagen, known as REDD (Reducing Emissions fr...to forest dwellers directly, and their property ri...
(Date:12/3/2009)... The UK leads the world when it comes to investmen...ngineering and Physical Sciences Research Council ...ore is needed: "Scientific and engineering researc...and solar power solutions, but more investment is ...lutions if we are to meet our carbon emission targ...
Breaking Biology News(10 mins):Fish with attitude: Some like it hot 2Forest deal at Copenhagen must avoid creating 'carbon refugees' 2Research is vital to a cleaner, greener, low carbon future 2FDA Warns Consumers Not to Use Stolen Albuterol Sulfate Inhalation Solution and Ipratropium Bromide Inhalation Solution 57579 1FDA Warns Consumers Not to Use Stolen Albuterol Sulfate Inhalation Solution and Ipratropium Bromide Inhalation Solution 57579 2Results of Ongoing Testing Show Air Quality is Safe Near Schools in Beaver and Erie Counties in Pennsylvania 57577 1Results of Ongoing Testing Show Air Quality is Safe Near Schools in Beaver and Erie Counties in Pennsylvania 57577 2Results of Ongoing Testing Show Air Quality is Safe Near Schools in Beaver and Erie Counties in Pennsylvania 57577 3BioCryst to Present at UBS Global Life Sciences Conference 57575 1BioCryst to Present at UBS Global Life Sciences Conference 57575 2
...rchers at the National Institute of Mental Health ... have discovered a genetically controlled brain me...-one of the most important but least understood as...n Nature Neuroscience, published online on July 10... volunteers to those with a genetic abnormality, W...
...ng Genomics Institute (BGI) of the Chinese Academy... Breeding and Production (DCPBP) jointly announce ...eleased sequence data include 3.84 million pieces ...ds from Europe and China. The data are generated f...fort, the Sino-Danish Pig Genome Project, started ...
...mphetamine, the drug of choice for long-distance t... appears to do a similar trick for fruit flies, to...hat demonstrates a critical role for the neurotran... and arousal states. , The work is reported by Dr....es Institute in San Diego. , The researchers foun...
Other Biology News:Scientists uncover new clues about brain function in human behavior 2Scientists uncover new clues about brain function in human behavior 3‘Blue Brain?project explores thought at molecular level 2
DETACHaBEAD CD19 from Dynal Biotech
REact 2 Buffer from Invitrogen
... The Vybrant Apoptosis Assay Kit #4 detects apop...rmeability of cell membranes. This kit contains re...m iodide nucleic acid stains. YO-PRO-1 stain selec...totic cells and labels them with moderate green fl...
Porcine TNF-alpha (TNFSF1A) ELISpot Development Kit from R&D Systems
Biology Products: